Core Viewpoint - AYR Wellness Inc. has entered into an Extended Agreement to extend the temporary waiver period related to its financial obligations, allowing for continued negotiations with senior lenders and exploration of strategic options to strengthen its capital structure [1][2][3] Group 1: Extended Agreement Details - The Extended Agreement extends the waiver period from June 19, 2025, to July 3, 2025 [1] - The waiver pertains to defaults related to the delay in filing interim financial statements for the quarter ended March 31, 2025, and specific payment defaults under other outstanding indebtedness [2] - This extension does not permanently waive existing defaults but facilitates ongoing dialogue to address financial obligations [3] Group 2: Company Overview - AYR Wellness is a leading vertically integrated U.S. multi-state cannabis operator with over 90 licensed dispensaries [5] - The company is committed to delivering high-quality cannabis products while positively impacting its team members and the communities it serves [5]

Core Points - Cannara Biotech Inc. is hosting a webcast investor presentation on June 25, 2025, at 2:00 PM ET, led by CFO Nicholas Sosiak [1] - The presentation will cover key areas of Cannara's business, followed by an interactive Q&A session for investors [1] - An archived version of the webcast will be available on the company's website [1] Company Overview - Cannara Biotech Inc. is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets [2] - The company operates two mega facilities in Québec, covering over 1,650,000 sq. ft., with a potential annualized cultivation output of 100,000 kg [2] - Cannara leverages Québec's low electricity costs to produce premium-grade cannabis products at competitive prices [2]

TORONTO, June 19, 2025 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company"), a leading consumer packaged goods company in the cannabis products market, is pleased to announce that it has entered into two agreements that will strengthen its balance sheet, reduce debt, and support long-term growth: A non-binding agreement (the "Term Sheet") to amend and restate the Company's existing syndicated credit facility led by the Bank of Montreal ("BMO"), and An exchange agreem ...

Core Insights - Verano Holdings Corp. has announced an exclusive partnership with Grow Sciences to introduce premium cannabis products to the Illinois market, starting June 21, 2025 [1][2][3] Group 1: Partnership Details - The partnership will initially offer Grow Sciences' products exclusively at Zen Leaf dispensaries in Illinois, with plans to expand to third-party dispensaries later [1][2] - Grow Sciences is recognized for its elite cannabis genetics and solventless extraction methods, and will introduce thirteen sought-after strains to Illinois, including Prickly Pear and Florida Jack [2][3] Group 2: Product Offerings - The product lineup includes flower eighths, 1-gram flower joints, live hash rosin cartridges, hash rosin extracts, and live rosin fruit chews, with various strains available for each product type [3][4] - Flower products will feature seven strains, while live hash rosin cartridges and extracts will include six strains each, showcasing the quality and variety of offerings [3][4] Group 3: Company Background - Verano Holdings is a leading multi-state cannabis operator with a mission to enhance the cannabis shopping experience across medical and adult-use markets [5] - The company operates in 13 U.S. states with over 1.1 million square feet of cultivation capacity, emphasizing quality and a diverse product portfolio [5]

Company Overview - FLUENT Corp. is a national cannabis consumer packaged goods company and retailer, committed to operational excellence in cultivation, production, distribution, and retail experience [1] - The company operates under the FLUENT™ brand and produces a diverse portfolio of cannabis products, including brands such as MOODS, Knack, Wandr, Bag-O, and Hyer Kind [1] - FLUENT operates in Florida, New York, Pennsylvania, and Texas, with its headquarters in Tampa, Florida [1] - The company employs 700 individuals across 8 cultivation and manufacturing facilities and has 42 active retail locations [1] Shareholder Meeting Results - The annual general and special meeting of shareholders resulted in the approval of all matters presented [1] - Key approvals included the election of seven directors: Robert Beasley, Roger Daher, Mark Eckenrode, Christopher Hagedorn, Richard Mavrinac, William Smith, and Dawn Sweeney [6] - PKF O'Connor Davies LLP was appointed as the auditor of the company [6] - The Hawthorne Collective, Inc. was approved as a new "Control Person" of the company [6]

PHOENIX, June 18, 2025 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA: TILT) (OTCPK: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announces the results of the 2025 annual general meeting of shareholders of TILT (the “Shareholders”) held virtually on Tuesday, June 17, 2025 (the “Meeting”). The Company put forward the following proposals to be voted on by the ...

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S. https://t.co/4EWz1fWTrh ...

Core Insights - Cannara Biotech Inc. has been recognized with two awards at the 2025 Grow Up Awards Gala, including Brand of the Year for its Tribal brand and Accessory of the Year for its Nugz Happle product, highlighting its commitment to product excellence and innovation in the Canadian cannabis industry [1][2][3] Financial Management - The company has made a $1 million repayment against its Olymbec convertible debenture, which was originally issued on June 21, 2021, reflecting a disciplined approach to capital management and a commitment to reducing leverage while maintaining financial flexibility [4] - Cannara has achieved a total reduction of 50 basis points in the interest rate spread on its BMO Credit Facility, resulting in an overall cost of debt now below 6%, underscoring its strong financial performance and disciplined capital structure management [6] Industry Recognition - The Grow Up Conference and Expo is recognized as one of Canada's leading industry events, with the Grow Up Awards being one of the industry's highest honors, selected through open voting by industry participants and the public [3]

Group 1 - High Tide Inc. reported strong fiscal Q2 results for the February-April period, indicating continued momentum in the Canna Cabana chain [1] - The company is recognized for its focus on small cap investments and aims to identify mispriced securities through understanding financial drivers and DCF model valuation [1] Group 2 - The performance of High Tide Inc. reflects the overall strength of the Canadian cannabis retail market [1]

Core Points - MediPharm Labs Corp. held its annual and special meeting where key resolutions were voted on by shareholders [1][2] - A total of 210,726,733 common shares were represented, accounting for 50.76% of the total issued shares [2] - The meeting resulted in the approval of several resolutions including the number of directors, appointment of auditors, election of directors, and unallocated awards under the equity incentive plan [3] Voting Results - The resolution to fix the number of directors at seven was approved with 75.46% voting in favor [5] - All management director nominees were elected with Chris Halyk receiving 144,007,422 votes and Emily Jameson receiving 144,289,930 votes [6] - MNP LLP was appointed as the auditor with 90.78% of votes in favor [7] - The resolution for unallocated awards under the equity incentive plan was narrowly approved with 50.14% voting for and 49.86% against [8] Board Changes - New directors Emily Jameson and John Medland were welcomed to the Board, while Michael Bumby did not stand for re-election [4] Company Overview - MediPharm Labs specializes in the development and manufacture of pharmaceutical-quality cannabis concentrates and advanced derivative products [9] - The company received a Pharmaceutical Drug Establishment License from Health Canada in 2021, making it the only North American company with a commercial-scale GMP license for cannabinoid extraction [10] - In 2023, MediPharm acquired VIVO Cannabis Inc., expanding its reach to medical patients in Canada, Australia, and Germany [11]